Home Newsfeeds Keybanc Upgrades KB Home to Sector Weight

Keybanc Upgrades KB Home to Sector Weight

Keybanc analyst Kenneth Zener upgrades KB Home (NYSE:KBH) from Underweight to Sector Weight.

byBenzinga Newsdesk

September 19, 2022

1 minute read

Keybanc analyst Kenneth Zener upgrades KB Home (NYSE:KBH) from Underweight to Sector Weight.

Jack Ma Gives Up Position In China’s Prestigious Guild – Read Why

By Anusuya Lahiri

December 8, 8:47 AM

Alibaba Group Holding Limited (NYSE: BABA) co-founder Jack Ma stepped down as the General Association of Zhejiang Entrepreneurs president, a position he has held since 2015.

BABA

Analyst Ratings

Forecasting The Future: 6 Analyst Projections For Emerson Electric

By Benzinga Insights

January 4, 12:00 PM

In the last three months, 6 analysts have published ratings on Emerson Electric (NYSE:EMR), offering a diverse range…

EMR

What’s Going On With Healthcare Logistics Giant Owens & Stock On Friday?

By Vandana Singh

May 3, 12:56 PM

Owens & Minor impresses with Q1 results: adjusted EPS of $0.19, and sales of $2.61B (up 4% Y/Y). Patient Direct revenue reaches $638M (up 5% Y/Y). CEO Edward Pesicka highlights growth strategies and reaffirms 2024 revenue guidance of $10.5-$10.9 billion and adjusted EPS of $1.40-$1.70.

OMI

EXCLUSIVE: Longeveron’s Heart Disease Cell Therapy Poised To Secure European Patent

By Vandana Singh

August 25, 7:30 AM

The European Patent Office has issued a notice of its intent to grant Longeveron Inc (NASDAQ: LGVN) a patent related to methods to treat endothelial dysfunction and monitor the efficacy of allogeneic mesenchymal cell therapies, also known as medicinal signaling cells (MSCs).

LGVN

Keybanc Upgrades KB Home to Sector Weight

Related Posts

Jack Ma Gives Up Position In China’s Prestigious Guild – Read Why

Forecasting The Future: 6 Analyst Projections For Emerson Electric

What’s Going On With Healthcare Logistics Giant Owens & Stock On Friday?

EXCLUSIVE: Longeveron’s Heart Disease Cell Therapy Poised To Secure European Patent